Cargando…
Glycosylated clusterin species facilitate Aβ toxicity in human neurons
Clusterin (CLU) is one of the most significant genetic risk factors for late onset Alzheimer’s disease (AD). However, the mechanisms by which CLU contributes to AD development and pathogenesis remain unclear. Studies have demonstrated that the trafficking and localisation of glycosylated CLU protein...
Autores principales: | Foster, Evangeline M., Fernandes, Marco, Dangla-Valls, Adria, Hublitz, Philip, Pangalos, Menelaos, Lovestone, Simon, Ribe, Elena M., Buckley, Noel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633591/ https://www.ncbi.nlm.nih.gov/pubmed/36329114 http://dx.doi.org/10.1038/s41598-022-23167-z |
Ejemplares similares
-
Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies
por: Foster, Evangeline M., et al.
Publicado: (2019) -
Clusterin Is Required for β-Amyloid Toxicity in Human iPSC-Derived Neurons
por: Robbins, Jacqueline P., et al.
Publicado: (2018) -
Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt–PCP–JNK pathway
por: Killick, R, et al.
Publicado: (2014) -
The Influence of Clusterin Glycosylation Variability on Selected Pathophysiological Processes in the Human Body
por: Janiszewska, Ewa, et al.
Publicado: (2022) -
Clusterin protects neurons against intracellular proteotoxicity
por: Gregory, Jenna M., et al.
Publicado: (2017)